| Financial Year |
March 31 2023 |
| Monetary Funds |
1,948,712,879.11 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
27,757,680.00 |
| Accounts Receivable |
2,397,251,350.19 |
| Advances to Suppliers |
273,137,461.55 |
| Other Receivables |
2,028,848,892.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
3,980,922.55 |
| Dividend Receivable |
-- |
| Inventories |
2,565,609,361.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
230,036,281.70 |
| Total Current Assets |
9,624,208,691.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
910,321,803.22 |
| Investment Properties |
-- |
| Fixed Assetes |
6,625,006,894.66 |
| Under-construction Projects |
188,664,630.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,658,703,211.55 |
| R&D expenses |
1,678,280,046.55 |
| Goodwill |
3,336,585.26 |
| Long-Term Deferred and Prepaid Expenses |
59,722,781.42 |
| Deferred Income Tax Assets |
50,265,148.03 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
12,195,707,368.62 |
| Total Assets |
21,819,916,060.13 |
| Short-Term Loans |
5,443,625,472.19 |
| Trading Financial liabilities |
-- |
| Notes Payable |
737,259,554.00 |
| Accounts Payable |
2,149,142,624.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
169,217,530.08 |
| Taxes Payable |
84,507,974.80 |
| Interest Payable |
603,204.27 |
| Dividend Payable |
385,687.50 |
| Other payables |
584,726,394.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,886,707,618.04 |
| Other Current Liabilities |
43,276,806.94 |
| Sub-Total of Current Liabilities |
12,378,136,288.63 |
| Long-term Loans |
2,797,412,754.43 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
900,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,207,103,231.87 |
| Total Liabilities |
15,585,239,520.50 |
| Paid-In Capital(Or Share Stock) |
1,715,730,370.00 |
| Capital Surplus |
3,886,387,018.14 |
| Surplus Reserve |
295,007,501.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-601,083,049.19 |
| Minority Stockholder's Interest |
929,376,540.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,305,299,999.21 |
| Owner's Equity（Stockholder's Equity） |
6,234,676,539.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,819,916,060.13 |
